[Community-acquired pneumonia: selection of empirical treatment and sequential therapy. SARS-CoV-2 implications]. / Neumonía comunitaria: selección del tratamiento empírico y terapia secuencial. Implicaciones del SARS-CoV-2.
Rev Esp Quimioter
; 34(6): 599-609, 2021 Dec.
Article
in Spanish
| MEDLINE | ID: covidwho-1498473
ABSTRACT
Pneumonia is a major cause of global mortality in developed countries. The adequacy of the antibiotic treatment is essential for the good evolution of the patients. When selecting the antimicrobial, the severity of the patient, the characteristics of the antibiotics, and the profile of the patient to be treated should be considered. Recommendations for the selection of antibiotic treatment may differ between the patient who requires admission and the one who can be treated as outpatient. Beta-lactams, fluoroquinolones, and macrolides are the most widely used antimicrobials in this last circumstance. However, not all are the same in terms of efficacy, safety and ecological impact. This review delves into the aforementioned aspects to improve decision-making and offers concrete recommendations for the selection of antibiotic treatment. Likewise, it includes recommendations for performing sequential therapy. Finally, a brief review is made about the impact of SARS-CoV-2 infection on this pathology.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia
/
Community-Acquired Infections
/
COVID-19
Type of study:
Prognostic study
Limits:
Humans
Language:
Spanish
Journal:
Rev Esp Quimioter
Journal subject:
Drug Therapy
Year:
2021
Document Type:
Article
Affiliation country:
Req
Similar
MEDLINE
...
LILACS
LIS